Detalhe da pesquisa
1.
Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses.
Arthritis Rheum
; 62(12): 3656-65, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20862679
2.
Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
Ann Rheum Dis
; 69(11): 2042-50, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20551157
3.
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.
J Leukoc Biol
; 85(2): 243-50, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18971286
4.
Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO.
Immunology
; 124(1): 89-101, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18067553
5.
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies.
Arthritis Res Ther
; 18(1): 302, 2016 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993172
6.
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.
PeerJ
; 4: e2300, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27635311
7.
Nociceptin-induced modulation of human T cell function.
Peptides
; 30(5): 926-34, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19428771